9.469
1.29%
0.139
Immunome Inc Azioni (IMNM) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
73.11%
1.029
|
3.826 | 3.565 | 4.263 | 2.364 |
Operating Expenses
|
35.39%
133.33
|
98.48 | 8.198 | 10.04 | 6.835 |
Benefits Costs and Expenses |
35.31%
130.52
|
96.46 | - | - | 6.634 |
Costs And Expenses |
35.31%
130.52
|
96.46 | 8.198 | 10.04 | 6.634 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
39.77%
-132.30
|
-94.65 | -4.633 | -5.773 | -4.471 |
Net Interest Income/Expense |
39.03%
2.807
|
2.019 | 0.288 | 0.216 | 0.201 |
Interest Income/Expense After Provision For Losses |
39.03%
2.807
|
2.019 | 0.288 | 0.216 | 0.201 |
Income/Loss From Continuing Operations Before Tax |
39.79%
-129.49
|
-92.63 | 3.565 | 4.263 | -4.27 |
Income/Loss From Continuing Operations After Tax |
39.79%
-129.49
|
-92.63 | -4.345 | -5.557 | -4.27 |
Net Income/Loss
|
39.79%
-129.49
|
-92.63 | -4.345 | -5.557 | -4.27 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
573.84%
51.54
|
7.6494 | 12.20 | 12.20 | 12.18 |
Diluted Average Shares |
573.84%
51.54
|
7.6494 | 12.20 | 12.20 | 12.18 |
Basic Earnings Per Share |
40.52%
-2.51
|
-4.22 | -0.36 | -0.46 | -0.35 |
Diluted Earnings Per Share |
40.52%
-2.51
|
-4.22 | -0.36 | -0.46 | -0.35 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):